PERITI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.033
AS - Asia 3.585
EU - Europa 3.495
SA - Sud America 481
OC - Oceania 110
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.979
RU - Federazione Russa 1.700
CN - Cina 1.039
SG - Singapore 1.014
HK - Hong Kong 553
KR - Corea 518
IE - Irlanda 492
BR - Brasile 394
SE - Svezia 316
UA - Ucraina 259
DE - Germania 239
IT - Italia 172
FI - Finlandia 141
IN - India 141
VN - Vietnam 133
AU - Australia 107
GB - Regno Unito 78
TR - Turchia 41
JO - Giordania 36
AR - Argentina 31
FR - Francia 29
JP - Giappone 29
CA - Canada 26
MX - Messico 18
PE - Perù 16
ZA - Sudafrica 14
EC - Ecuador 13
ES - Italia 13
BD - Bangladesh 12
NL - Olanda 12
PL - Polonia 12
BJ - Benin 9
CI - Costa d'Avorio 9
IQ - Iraq 9
SC - Seychelles 9
UY - Uruguay 8
VE - Venezuela 8
CH - Svizzera 7
ID - Indonesia 7
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CL - Cile 5
MA - Marocco 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
OM - Oman 4
AL - Albania 3
BE - Belgio 3
CO - Colombia 3
CR - Costa Rica 3
DZ - Algeria 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PY - Paraguay 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
DK - Danimarca 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 13.763
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.710
Singapore 705
Seoul 502
Dublin 491
Hefei 488
Chandler 476
Jacksonville 470
Hong Kong 436
Fairfield 353
Ashburn 307
Cambridge 157
Woodbridge 146
Buffalo 129
Seattle 125
Wilmington 125
Los Angeles 123
Houston 114
Beijing 112
Melbourne 99
Mumbai 90
The Dalles 89
Princeton 86
Boardman 73
Boston 65
Kent 53
Lawrence 51
Ho Chi Minh City 50
Moscow 47
Medford 45
Ann Arbor 43
Dallas 43
Munich 42
Altamura 41
New York 41
San Jose 33
Shanghai 33
Hanoi 32
São Paulo 32
Helsinki 31
Tokyo 29
Milan 28
San Diego 23
Bengaluru 22
Turku 19
Norwalk 18
West Jordan 18
Auburn Hills 17
Pune 17
Tianjin 15
Hillsboro 14
Izmir 12
Lima 12
Abidjan 9
Andover 9
Brasília 9
Brooklyn 9
Cotonou 9
Florence 9
Paris 9
Warsaw 9
Dearborn 8
Frankfurt Am Main 8
Montreal 8
Denver 7
Redondo Beach 7
Redwood City 7
Rio de Janeiro 7
Yubileyny 7
Bern 6
Iksan 6
Johannesburg 6
London 6
Phoenix 6
Porto Alegre 6
Tashkent 6
Toronto 6
Volta Redonda 6
Baghdad 5
Belo Horizonte 5
Chennai 5
Curitiba 5
Da Nang 5
Dong Nai 5
Frankfurt am Main 5
Guangzhou 5
Guarulhos 5
Guayaquil 5
Haiphong 5
Montevideo 5
Orem 5
Recife 5
Rio Grande 5
Santo André 5
Secaucus 5
Taipei 5
Washington 5
Baku 4
Canoas 4
Charlotte 4
Dhaka 4
Totale 8.628
Salva come PNG Salva come JPEG
Nome #
[Medical therapy of malignant melanoma] 220
Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. 159
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 158
In vitro brodimoprim activity on nosocomial bacterial strains. 149
Adverse effects of macrolide antibacterials. 146
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. 145
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro 137
Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis 136
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 135
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) 134
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 134
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 134
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 134
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin 133
Ofloxacin concentrations in human inflamed pericoronal tissue after oral administration. 132
Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery. 132
Phase I clinical trial of a new alkylating agent, PTT-119 130
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 130
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI) 127
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 127
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 126
Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses. 125
[Plasma and tissue antibiotic concentrations: what is their prognostic value?] 125
Phase I trial of a novel alkylating agent 125
PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA. 124
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a). 123
[Antibiotic prophylaxis of postoperative infection in orthopedics. Results of an epidemiologic survey in Italy conducted by the Journal of Chemotherapy] 122
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 122
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 122
Preliminary results of a phase II multicenter study on the clinical efficacy and safety to the LH-RH analog leuprolide in the treatment of prostatic carcinoma 121
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. 121
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 120
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 120
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. 120
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 119
Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci 119
Oral medroxyprogesterone acetate pharmacokinetics: results in a group of patients during a controlled clinical trial on stage I endometrial carcinoma. 119
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. 118
Clinical pharmacokinetics of depot leuprorelin. 118
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 117
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain. 117
Pharmacokinetics and blister fluid penetration of brodimoprim in adults. 117
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. 116
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM 115
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 115
Beta-lactamase evaluation of the amoxycillin-clavulanate association. 115
Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency. 115
Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions. 115
Tissue distribution of antimicrobial drugs. 114
Chemoresistance to fosfomycin: a bacteriological study. 114
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU) 113
Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. 113
New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. 113
A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer 112
Clinical pharmacokinetics of cefpodoxime proxetil in older patients 111
Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. 111
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. 111
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 110
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells 109
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. 109
Tissue distribution of cefotetan in patients with Crohn's disease. 109
The suction blister technique as a tool in antimicrobial drug pharmacokinetics. 109
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer. 109
Selecting antibacterial agents for the control of surgical infection: mini-review. 109
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 108
High dose fosfomycin: indications, tolerance and pharmacokinetics. 108
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 107
Teicoplanin: its role as systemic burn therapy and as prophylaxis for orthopedic surgery 106
Drug resistance in cancer: an overview of the clinical aspects. 106
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 103
Perioperative chemotherapy in thet reatment of carcinoma of the uterine cervix 103
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 102
Ceftizoxime concentrations in human aqueous humor following intravenous administration. 98
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion 97
Fluoropyrimidine-folate synergy in human leukemia-lymphoma cells in culture 96
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano. 94
Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. 93
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 91
Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma 90
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. 89
Clinical pharmacokinetics and tissue penetration of teicoplanin 88
Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study 88
Concentration-effect relationship for antimicrobial drugs. 88
Pharmacokinetics and endocrine effects of leuprolide depot 87
Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment. 87
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 87
Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo 87
Clarithromycin: pharmacokinetics and pharmacodynamics 86
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections 85
Penicilline, cefalosporine e altre beta-lattamine. 85
Pharmacokinetic drug interaction of macrolides 84
Clinical pharmacokinetics and tissue penetration of teicoplanin. 84
Infections in immunocompromised patients. II. Established therapy and its limitations. 84
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). 83
Single-dose ceftriaxone vs. multiple-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter propsective randomized study 83
Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery. 82
Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study. 82
Microbiological and pharmacokinetic evaluation of cefonicid 81
Phase I study of LY186641, a diarylsulfonylurea given on alternative weeks to patients with solid tumours 81
Comparison of the antimicrobial prophylactic efficacy of cefotaxime and cephazolin in obstetric and gynaecological surgery. A randomised multicentre study. 81
Totale 11.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021504 0 0 0 0 0 129 19 101 34 97 33 91
2021/2022471 8 61 4 39 13 15 5 38 22 8 135 123
2022/20231.783 136 159 33 182 192 401 279 111 204 10 50 26
2023/2024689 44 81 147 32 55 121 10 149 4 22 10 14
2024/20254.992 183 543 254 704 1.362 746 60 215 298 117 220 290
2025/20263.475 666 962 760 539 439 109 0 0 0 0 0 0
Totale 13.826